Q2 2016 Holdings
Filed 2016-08-15 | 23 holdings | $21.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $14.7M | 493,630 | 67.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.4M | 70,000 | 24.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.7M | 291,230 | 7.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $14.3K | 705,159 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $9.4K | 232,600 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.0K | 100,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.0K | 20,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACHC) | COM | 00404A109 | $6.5K | 200,938 | 0.0% |
| Tesaro Inc | COM | 881569107 | $6.3K | 75,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $6.2K | 450,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $5.8K | 877,753 | 0.0% |
| Avexis Inc | COM | 05366U100 | $5.4K | 142,664 | 0.0% |
| Aradigm Corp(ARDMEUR) | COM NO PAR NEW | 038505400 | $4.8K | 1,101,513 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.1K | 757,935 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.3K | 234,220 | 0.0% |
| Akari Therapeutics PLC | SPONSORED ADR | 00972G108 | $1.9K | 139,899 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.9K | 93,331 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.7K | 633,692 | 0.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $1.7K | 1,000,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $1.6K | 700,000 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $1.3K | 176,710 | 0.0% |
| Nexvet Biopharma PUB LTD Co | ORD SHS | G6503X109 | $720 | 154,840 | 0.0% |
| Essa Pharma Inc | COM | 29668H104 | $83 | 28,100 | 0.0% |